Literature DB >> 1709818

A study, by electron microscopy, of the specific uptake of alpha-fetoprotein by mouse embryonic fibroblasts in relation to in vitro aging, and by human mammary epithelial tumour cells in comparison with normal donors' cells.

M Geuskens1, T Dupressoir, J Uriel.   

Abstract

A covalent conjugate of alpha-foetoprotein (AFP) and horseradish peroxidase (HRP) has been used to follow the internalization pathway of this serum protein in early and late passages of primary cultures of mouse embryonic fibroblasts as well as in a spontaneously immortalized cell line. AFP, as transferrin (Tf) used in parallel as a control, are endocytosed through coated pits and vesicles and move then to endosomes in every case; in cells of the late passages, at least a part of the internalized proteins would be routed to lysosomes. Cells of three different established human mammary cancer lines (MCF-7, Evsa-T, T-47D) internalize AFP-HRP through coated pits and vesicles. Such localization of the conjugate is practically never detected in normal human mammary epithelial cells in primary culture. Taken together, these results are in agreement with the view that AFP receptors are expressed at the surface of proliferating mouse embryonic fibroblasts and human mammary epithelial cancer cells but absent from the surface of normal human mature cells of the same origin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709818

Source DB:  PubMed          Journal:  J Submicrosc Cytol Pathol        ISSN: 1122-9497


  2 in total

Review 1.  Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family.

Authors:  Gerald J Mizejewski
Journal:  Tumour Biol       Date:  2010-12-01

2.  Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma.

Authors:  Angela D Pardee; Hiroshi Yano; Aliyah M Weinstein; Aaron A K Ponce; Alexander D Ethridge; Daniel P Normolle; Lazar Vujanovic; Gerald J Mizejewski; Simon C Watkins; Lisa H Butterfield
Journal:  J Immunother Cancer       Date:  2015-07-21       Impact factor: 13.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.